Care and management of osteoarthritis in adults: summary of NICE guidance

doi:10.1136/bmj.39490.608009.AD

BMJ 2008;336:502-503 (1 March), doi:10.1136/bmj.39490.608009.AD

Practice

Guidelines

Care and management of osteoarthritis in adults: summary of NICE guidance

Philip G Conaghan, professor of musculoskeletal medicine¹, John Dickson, community physician in rheumatology ², Robert L Grant, senior technical adviser at National Collaborating Centre for Chronic Conditions, and medical statistician³, on behalf of the Guideline Development Group

¹ Section of Musculoskeletal Disease, University of Leeds, Leeds LS7 4SA , ² Redcar and Cleveland Primary Care Trust, Guisborough Primary Care Hospital, Guisborough TS14 6HZ , ³ Royal College of Physicians of London, London NW1 4LE

Correspondence to: P Conaghan, Section of Musculoskeletal Disease, Chapel Allerton Hospital, Leeds LS7 4SA p.conaghan@leeds.ac.uk

The first 150 words of the full text of this article appear below.

Osteoarthritis refers to a syndrome of joint pain accompaniedby functional limitation and reduced quality of life. It isthe most common form of arthritis and one of the leading causesof pain and disability in the United Kingdom. The publishedevidence for osteoarthritis treatment has many limitations—typically,short duration studies using single drug treatments. However,people with osteoarthritis need to be aware of the treatmentsthat represent core management and of the range of additionaltreatments available. This article summarises the most recentrecommendations from the National Institute for Health and ClinicalExcellence (NICE) on the care and management of osteoarthritisin adults.¹

NICE recommendations are based on systematic reviews of bestavailable evidence. When minimal evidence is available, recommendationsare based on the guideline development group’s opinionof what constitutes good practice. Evidence levels for the recommendationsare given in italic in square brackets.

Assess the effect of . . . [Full text of this article]

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

StumbleUpon Add to Technorati

Technorati What's this?

Relevant Articles

Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis: Nicholas Latimer, Joanne Lord, Robert L Grant, Rachel O’Mahony, John Dickson, Philip G Conaghan on behalf of the National Institute for Health and Clinical Excellence Osteoarthritis Guideline Development Group
BMJ 2009 339: b2538. [Abstract] [Full Text] [PDF]

ARTIST (osteoarthritis intervention standardized) study of standardised consultation versus usual care for patients with osteoarthritis of the knee in primary care in France: pragmatic randomised controlled trial: P Ravaud, R-M Flipo, I Boutron, C Roy, A Mahmoudi, B Giraudeau, and T Pham
BMJ 2009 338: b421. [Abstract] [Full Text] [PDF]

Commentary: controversies in NICE guidance on osteoarthritis: Nicola Dalbeth and Bruce Arroll
BMJ 2008 336: 504. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

Latimer, N., Lord, J., Grant, R. L, O'Mahony, R., Dickson, J., Conaghan, P. G, on behalf of the National Institute for Health and, (2009). Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis. BMJ 339: b2538-b2538 [Abstract] [Full text]
Croft, P., Porcheret, M. (2009). Standardised consultations in primary care. BMJ 338: b152-b152 [Full text]
Ravaud, P, Flipo, R-M, Boutron, I, Roy, C, Mahmoudi, A, Giraudeau, B, Pham, T (2009). ARTIST (osteoarthritis intervention standardized) study of standardised consultation versus usual care for patients with osteoarthritis of the knee in primary care in France: pragmatic randomised controlled trial. BMJ 338: b421-b421 [Abstract] [Full text]